Skip to main content
. 2023 Jul 4;14(9):1503–1515. doi: 10.1007/s13300-023-01435-z

Fig. 1.

Fig. 1

Study timeline. BBIT Basal-bolus insulin therapy, CGM continuous glucose monitoring, CGM on BBIT CGM on basal-bolus insulin therapy, CGM on IDegLira CGM on IDegLira, IDegLira fixed combination of insulin degludec and the glucagon-like peptide-1 receptor agonist (GLP1-RA) liraglutide, SMBG self-monitoring of blood glucose, TDDI total daily dose of insulin. Asterisk refers to a subgroup of 55 patients who underwent also continual CGM